Supernus Pharmaceuticals Stock Forecast
Supernus Pharmaceuticals stock price ended at $30.26 on Wednesday, after gaining 1.04%.
(Updated on Apr 24, 2024)
The Supernus Pharmaceuticals stock price gained 1.04% on the last trading day (Wednesday, 24th Apr 2024), rising from $29.95 to $30.26. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 1.93% from a day low at $29.82 to a day high of $30.40. The price has been going up and down for this period, and there has been a -4.96% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 4 thousand more shares were traded than the day before. In total, 195 thousand shares were bought and sold for approximately $5.90 million.
The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $29.16 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 13.79% during the next 3 months and, with a 90% probability hold a price between $33.18 and $41.90 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
SUPN Signals & Forecast
A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 4.81%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Supernus Pharmaceuticals stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $32.21. On a fall, the stock will find some support from the short-term average at $29.52. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Supernus Pharmaceuticals stock
Supernus Pharmaceuticals finds support from accumulated volume at $29.70 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.575 between high and low, or 1.93%. For the last week, the stock has had daily average volatility of 3.72%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (SUPN) For The Upcoming Trading Day Of Thursday 25th
For the upcoming trading day on Thursday, 25th we expect Supernus Pharmaceuticals to open at $30.16, and during the day (based on 14 day Average True Range), to move between $29.04 and $31.48, which gives a possible trading interval of +/-$1.22 (+/-4.04%) up or down from last closing price. If Supernus Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 8.08% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $30.69 (1.42%) than the support at $29.70 (1.85%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Supernus Pharmaceuticals stock A Buy?
Supernus Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score: -1.728 Sell Candidate Unchanged
Predicted Opening Price for Supernus Pharmaceuticals of Thursday, April 25, 2024
| Fair opening price April 25, 2024 | Current price |
|---|---|
| $30.16 ( 0.336%) | $30.26 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for SUPN
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 30.73 | 1.56 % | |
| R2 | 30.51 | 0.84 % | ||
| R1 | 30.38 | 0.390 % | ||
| Current price: | 30.26 | |||
| Support | S1 | 29.94 | -1.06 % | |
| S2 | 29.80 | -1.51 % | ||
| S3 | 29.58 | -2.24 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 31.43 | 3.87 % | |
| R2 | 31.08 | 2.71 % | ||
| R1 | 30.69 | 1.42 % | ||
| Current price | 30.26 | |||
| Support | S1 | 29.70 | -1.85% | |
| S2 | 29.50 | -2.51% | ||
| S3 | 28.35 | -6.31% |
FAQ
Click here for our free guide on how to buy Supernus Pharmaceuticals Stock.
